JPWO2023100745A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2023100745A5
JPWO2023100745A5 JP2023564923A JP2023564923A JPWO2023100745A5 JP WO2023100745 A5 JPWO2023100745 A5 JP WO2023100745A5 JP 2023564923 A JP2023564923 A JP 2023564923A JP 2023564923 A JP2023564923 A JP 2023564923A JP WO2023100745 A5 JPWO2023100745 A5 JP WO2023100745A5
Authority
JP
Japan
Prior art keywords
cells
composition according
cd11b
substance
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023564923A
Other languages
English (en)
Japanese (ja)
Other versions
JP7665047B2 (ja
JPWO2023100745A1 (cg-RX-API-DMAC7.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/043424 external-priority patent/WO2023100745A1/ja
Publication of JPWO2023100745A1 publication Critical patent/JPWO2023100745A1/ja
Publication of JPWO2023100745A5 publication Critical patent/JPWO2023100745A5/ja
Application granted granted Critical
Publication of JP7665047B2 publication Critical patent/JP7665047B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023564923A 2021-12-02 2022-11-24 免疫賦活化組成物 Active JP7665047B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021196561 2021-12-02
JP2021196561 2021-12-02
PCT/JP2022/043424 WO2023100745A1 (ja) 2021-12-02 2022-11-24 免疫賦活化組成物

Publications (3)

Publication Number Publication Date
JPWO2023100745A1 JPWO2023100745A1 (cg-RX-API-DMAC7.html) 2023-06-08
JPWO2023100745A5 true JPWO2023100745A5 (cg-RX-API-DMAC7.html) 2024-05-07
JP7665047B2 JP7665047B2 (ja) 2025-04-18

Family

ID=86612110

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023564923A Active JP7665047B2 (ja) 2021-12-02 2022-11-24 免疫賦活化組成物

Country Status (7)

Country Link
US (1) US20250127889A1 (cg-RX-API-DMAC7.html)
EP (1) EP4442279A4 (cg-RX-API-DMAC7.html)
JP (1) JP7665047B2 (cg-RX-API-DMAC7.html)
CN (1) CN118613283A (cg-RX-API-DMAC7.html)
CA (1) CA3239834A1 (cg-RX-API-DMAC7.html)
TW (1) TW202330902A (cg-RX-API-DMAC7.html)
WO (1) WO2023100745A1 (cg-RX-API-DMAC7.html)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5650780B2 (ja) * 2012-04-04 2015-01-07 日東電工株式会社 ワクチン組成物
CN103961700A (zh) * 2013-02-05 2014-08-06 日东电工株式会社 粘膜给予用疫苗组合物
JP6977206B2 (ja) * 2016-03-31 2021-12-08 富山県 自然免疫を活性化する粘膜ワクチン用アジュバント
CN109982695A (zh) * 2016-08-18 2019-07-05 国立大学法人奈良先端科学技术大学院大学 免疫调节剂
CN112105371B (zh) * 2018-02-09 2024-12-17 内斯托尔株式会社 脂多糖控制性肠道细菌及其用途

Similar Documents

Publication Publication Date Title
TWI418355B (zh) 使用失活的益生菌(probiotic)的方法及含彼之產物
CN107404925A (zh) 用于预防或治疗婴儿或幼儿胃肠感染/炎症的组合物
TW201100087A (en) Lactobacillus johnsonii La1 NCC533 (CNCM I-1225) and immune disorders
TW200936147A (en) Prevention and treatment of secondary infections following viral infection
TW201103552A (en) Non-replicating micro-organisms and their immune boosting effect
Wang et al. Probiotic bacteria: a viable adjuvant therapy for relieving symptoms of rheumatoid arthritis
WO2009151330A1 (en) Nutritional composition for infants delivered via caesarean section
CN104224851B (zh) 动物双歧杆菌乳酸亚种CGMCC No.9273的应用
WO2012173163A1 (ja) 菌体破砕物及びその配合物
Vilahur et al. Lactobacillus plantarum CECT 7315/7316 intake modulates the acute and chronic innate inflammatory response
TWI761849B (zh) 含有棒狀桿菌屬菌株及其培養物的用於預防、治療或改善胃病症的組成物
JP7554462B2 (ja) 腸内フローラ改善剤
TW201100541A (en) Process for producing lactic acid bacterium having enhanced immunomodulating activity
KR20180112257A (ko) 어류의 에드워드병 예방 또는 치료용 약학 조성물, 및 어류의 에드워드병 예방 및 치료 방법
JP2005537236A (ja) プロバイオティック治療
JP2010150206A (ja) 粘膜免疫賦活作用および免疫バランス調整作用を有する経腸栄養剤
JP5209294B2 (ja) インターロイキン12産生促進剤
JP2021050289A (ja) 皮膚常在細菌lps及びその配合物
CN105246479A (zh) 用于控制与体液免疫应答的过度激活相关的炎症过程的d-荞麦碱
Kamilya et al. Probiotics as Vaccine Adjuvants
CN112203523B (zh) 用于饲料添加剂中的益生菌组合物
Haris Modulation of immune system by taking probiotic bacteria: Especially focus on lactic acid bacteria
CN1269490C (zh) 抑制感染组合物及含有该组合物的饮食品
KR20190046731A (ko) 어류의 에드워드병 예방 또는 치료용 약학 조성물, 및 어류의 에드워드병 예방 및 치료 방법
TWI742333B (zh) 胺基酸亞鐵螯合物在治療腸道病原體感染以及提升生長性能上的用途